Research

Study shows that severe inflammation weakens the body’s ability to fight acute myeloid leukemia (AML).

The research team joins four other multidisciplinary teams around the country.

Managing insurance in a fragmented healthcare system is a “big burden,” says Dr. Asher D. Aladjem.

The findings may help explain poor air quality in the nation’s largest underground transit system.

Changes in key gene were found to drive development of a common lung cancer.

Patients with melanoma benefit from a vaccine that uses the technology later adopted to fight COVID-19.

The current way of measuring radiation dermatitis severity does not account for variability in skin of color.

The Phase 1 Developmental Therapeutics Program assesses treatments in the earliest stage of clinical trials.

The findings may help explain why some implant recipients respond so much more quickly than others.

Dr. William C. Huang says the agent could be a paradigm-changing method of treating some bladder cancers.